An expert review on refractory constipation established 14 best practice statements addressing key clinical issues for the ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...

Epkinly monotherapy significantly improved progression-free survival in relapsed/refractory DLBCL patients, reducing cancer ...

A new update from the American Gastroenterological Association (AGA) is calling for greater caution before surgery is considered for patients with refractory constipation, a severe, chronic form of ...

Researchers noted that despite the promising findings, more novel treatments are needed to overcome the disease’s resistance. Patients with penta-relapsed refractory multiple myeloma (RRMM) exhibited ...

Patients were randomly assigned on a 1:1 basis to receive teclistamab as monotherapy or physician’s choice of ...

Chronic constipation affects 8–12% of Americans. While most patients improve with conventional treatments, a small but challenging subset remains refractory. These patients often undergo extensive ...